Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc. | 6 | 0 | 2 | 0 | €2.17 | €4.39 | 102.178% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.90 | - | - |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €370.30 | €419.64 | 13.323% |
| United Therapeutics | 20 | 0 | 2 | 0 | €253.90 | €287.40 | 13.195% |
| Codexis Inc. | 7 | 2 | 2 | 0 | €3.24 | €8.36 | 157.717% |
| Abbott Laboratories | 18 | 0 | 2 | 0 | €95.77 | €116.48 | 21.625% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €2.54 | €12.21 | 380.744% |
| Rigel Pharmaceutical Inc. | 11 | 0 | 2 | 0 | €0.90 | €13.78 | 1434.930% |
| PTC Therapeutics Inc. | 15 | 8 | 2 | 3 | €33.60 | €41.51 | 23.549% |
| AnaptysBio Inc | 8 | 1 | 2 | 0 | €21.80 | €45.21 | 107.385% |
| AbbVie Inc. | 23 | 0 | 2 | 0 | €154.84 | €174.43 | 12.654% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 3 | 0 | €14.48 | €24.13 | 66.666% |
| Regeneron Pharmaceuticals Inc. | 37 | 1 | 3 | 0 | €919.00 | €961.13 | 4.584% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €26.40 | €47.53 | 80.030% |
| Exact Sciences | 14 | 0 | 3 | 0 | €41.04 | €82.22 | 100.353% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €2.26 | €8.55 | 277.451% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.59 | €4.62 | 686.553% |
| Edwards Lifesciences Corp. | 27 | 1 | 3 | 0 | €80.52 | €88.15 | 9.480% |
| Boston Scientific | 48 | 0 | 3 | 0 | €70.00 | €73.64 | 5.199% |
| Cigna Corp. | 18 | 0 | 3 | 0 | €310.35 | €345.35 | 11.276% |
| Eli Lilly Corp. | 49 | 0 | 3 | 0 | €768.50 | €786.51 | 2.343% |
| Halozyme Therapeutics Inc. | 16 | 0 | 3 | 0 | €47.22 | €47.07 | -0.312% |
| Insulet Corp. | 17 | 0 | 3 | 0 | €176.75 | €216.46 | 22.467% |